Dine Brands Global, Inc. (DIN): One of the Underperforming Stocks Targeted By Short Sellers
We recently published a list of . In this article, we are going to take a look at where Dine Brands Global, Inc. (NYSE:DIN) stands against other underperforming stocks targeted by short sellers.
Short interest refers to the percentage of publicly available shares that have been sold short. It is an indicator used by many investors to determine how strong a company's bear thesis may be. Due to the nature of short selling, the short interest has become a popular indicator among investors.
The reason it is given so much weightage is that people betting against a stock have usually done solid research and are confident of a company's downfall. They take unlimited risk, so when big investors or the smart money shorts a stock, people take notice. They try to unearth the red flags that may have prompted the high short interest.
We decided to dig deeper and try to find out where smart money sees trouble ahead. To come up with our list of 20 underperforming stocks targeted by short sellers, we looked at the worst-performing stocks of the last six months and then ranked them by the short interest.
A family enjoying their meal at a restaurant from the company's franchise operations.
Short interest: 17.68%
6 months' performance: -34.93%
Dine Brands Global, Inc. (NYSE:DIN) operates as an owner, franchisor, and operator of restaurants. It operates in the company restaurant operations, Rental operations, Franchise operations, and Financing operations segments.
The firm's Q4 2024 quarterly earnings shattered investor sentiment, something that didn't significantly improve after yesterday's Q1 2025 earnings call either. Dine Brands Global (NYSE:DIN) reported a 4.1% revenue growth, which finally broke the 7-quarter falling revenue streak. EOS came in at $1.03, missing estimates by $0.21 while revenue clocked in at $214.8 million, missing estimates by $0.29 million.
As per the guidance, the management expects the Applebee's same-store sales growth in a range of -2% to 1% year-over-year. IHOP same-store sales are anticipated to be between -1% to 2% year-over-year.
Overall, DIN ranks 6th on our list of underperforming stocks targeted by short sellers. While we acknowledge the potential of DIN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DIN but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
27 minutes ago
- Business Wire
Voya Investment Management survey reveals DC specialists are more aligned with participant views on retirement readiness versus plan sponsors
NEW YORK--(BUSINESS WIRE)--Voya Investment Management (Voya IM), the asset management business of Voya Financial, Inc. (NYSE: VOYA), today released new findings from its 2025 Survey of the retirement landscape. 'Challenges and Opportunities for Defined Contribution (DC) Specialists' offers insights into the evolving perceptions and practices of those who advise, sponsor and benefit from employer-sponsored retirement savings programs. This is the fifth edition of the survey, with previous waves conducted in March 2023, March 2021, December 2018, and April 2016. While participants are feeling more optimistic regarding their retirement, as in 2023, sponsors continued to overestimate participants' sense of their retirement readiness. 91% of sponsors thought participants were either 'very' or 'somewhat' prepared, whereas only 69% of participants felt that way. The good news is that participant confidence increased since 2023, up from 63%. Meanwhile, DC specialists' views were more in line with participants', with 70% saying that participants are 'very' or 'somewhat' prepared (versus 71% in 2023). 'This level of confidence from sponsors isn't unusual,' said Brian Houston, senior vice president, Business Development Manager, DCIO, Voya IM. 'Sponsors have generally felt that participants are better prepared for retirement than specialists have. One of the many factors driving this optimism may be the long-running equity bull market. However, it's crucial that participants are properly invested and have appropriate asset allocation, especially in a volatile market environment. Both sponsors and specialists agree on this point, and it's a key focus for helping participants achieve their retirement goals.' The survey also highlights a growing interest among sponsors and participants in solutions for generating income in retirement, signaling a shift toward more outcome-oriented retirement planning. Other key findings of the report include: Target date funds (TDFs) remain a staple: Specialists and sponsors continue to see TDFs as key components of DC plans. Three in four specialists include them in the plans they advise, while three in five sponsors have them in their plan. Of the sponsors who don't, nearly half would like to in the future. Interest in retirement income options gain traction: While specialists were more likely to believe that plan sponsors prioritize investment selection and monitoring, sponsors place a higher value on guidance among retirement income options, ranking it considerably higher than what specialists perceived. The percentage of participants that are caregivers and those with special needs are underestimated: Specialists and plan sponsors recognized the importance of addressing the specific financial needs of caregivers. However, more than 80% of both groups estimated that caregivers made up less than 20% of plan participants. According to AARP data, the real number is likely far higher based on the incidence of caregiving in the general population. Bridging Perspectives: Sponsors and Specialists Align on Retirement Readiness Challenges and Opportunities As in 2023, sponsors and specialists continued to have generally similar views on the most challenging barriers to participant retirement readiness. Both groups agreed the top barrier is insufficient participant contributions to the plan. Sponsors cited participants taking loans, hardship withdrawals or other types of withdrawals as the second most important barrier, while specialists ranked participants not knowing how much they'll need in retirement in that position. Compared to the previous survey, this year's sponsor and specialist responses showed greater alignment on key barriers to retirement readiness. Both groups highlighted a lack of understanding and support for retirement income generation, as well as participant investment strategies that are either overly aggressive or too conservative. Retirement Income Options and Investment Menus Sponsors cited guidance on retirement income investment options as the top service they want from their specialist, and 77% identified adding a retirement income solution or product as an important area of focus in the next two years. According to 83% of sponsors, the SECURE Act of 2019 and the SECURE 2.0 Act of 2022 have encouraged a strong focus on retirement income. Nine out of 10 sponsors agreed that there has been greater focus on the need for retirement income solutions in DC plans due to an aging participant base. This sentiment was even stronger among sponsors of larger plans. Sponsors and specialists were fairly aligned in their opinions on how to structure the plan's investment menu. 91% of sponsors and 88% of specialists agreed that offering a tiered investment menu— i.e., TDFs, core funds, and a self-directed brokerage/mutual fund window—for different types of participants can result in a better investing experience. One area of variance between sponsors and specialists centered around the number of investment options in the plan. 70% of sponsors said offering too many choices could inhibit effective participant investment decisions (down from 82% in 2023), while specialists' views on this remained stable since the previous survey (88%). Opportunities for DC specialists 'We see a significant opportunity for DC specialists to lead in the delivery of products such as TDFs or retirement income products,' said Houston. 'Our data show strong alignment between sponsors and specialists on the importance of supporting participants' holistic financial well-being. This opens the door for specialists to provide targeted education and personalized messaging—especially around guidance on retirement income investing options, which sponsors ranked as their top priority.' Voya's survey also showed that specialists were more likely to indicate they always or usually recommend or discuss plan features with sponsors than sponsors perceived, suggesting an opportunity for specialists to strengthen their communication skills especially when conveying their value / expertise. Sponsor and specialist views on the goals of financial wellness programs were generally well aligned. Sponsors identified helping participants with holistic financial wellness as an important area of focus, which presents an excellent opportunity for specialists to assist. Methodology From mid-January to mid-February 2025, we conducted an online survey of retirement plan sponsors and DC specialists focused on the retirement plan market. As in 2023, we included contributing participants in the survey to better understand their perspectives on issues such as retirement readiness, investing, and financial confidence. Voya Consumer Insights & Research assisted Voya IM with the development, execution, and analysis of the retirement plan participant survey. This survey was crafted to complement the plan sponsor and DC specialist surveys conducted with Brookmark Research. An online survey was conducted among 500 benefits-eligible, employed Americans who were actively contributing to their employer-sponsored retirement plan. The study distinguishes specialists by type: heavy-focus DC specialists, whose practices emphasize plan sponsor clients, and emerging DC specialists, for whom plan sponsors represent a smaller proportion of business. The study also segments sponsors based on plan size: $1-5 million, $5-25 million, and over $25 million. About Voya Investment Management Voya Investment Management delivers actively managed public and private market solutions that drive differentiated outcomes for clients worldwide. Our team of 300+ investment professionals manages approximately $344 billion in assets as of March 31, 2025. We excel at partnering with clients to understand their needs and address challenges in innovative ways, drawing on extensive expertise across fixed income, equity, and multi-asset strategies. VOYA-IM
Yahoo
41 minutes ago
- Yahoo
CERo Therapeutics, Inc. Announces Option Exercise for Additional Series D Financing
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) ('CERo'), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that the Company has issued additional shares of its Series D Preferred Stock to certain institutional investors (the 'Investors') pursuant to the securities purchase agreement previously entered into by and between the Company and such Investors on April 22, 2025 with respect to the issuance of shares of Series D Preferred Stock for an aggregate purchase price of up to $8 million, including $5 million previously issued in April 2025 and up to $3 million issuable at the option of the Investors. The shares of Series D Preferred Stock are convertible into shares of the Company's common stock. 'We welcome this vote of confidence and the continued support of our investors as we continue to show progress along our clinical timeline. The completion of our first-in-human dosing represents a significant clinical development milestone in AML for CER-1236, a novel autologous CAR-T therapeutic candidate targeting TIM 4L, and we will continue to communicate results as the data matures,' said Chris Ehrlich, Chief Executive Officer. The gross proceeds to CERo from today's closing are expected to be approximately $750,000, with up to $2.25 million of cash that may be funded at one or more additional closings, at the election of the Investors. CERo intends to use the net proceeds from the offering to take advantage of the two recent FDA IND allowances in liquid and solid tumors and complete the previously announced site activation at MDACC, as well as bring other sites online quickly. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is expected to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what CERo refers to as Chimeric Engulfment Receptor T cells ('CER-T'). CERo believes the differentiated activity of CER-T cells will afford them greater therapeutic application than currently approved chimeric antigen receptor ('CAR-T') cell therapy, as the use of CER-T may potentially span both hematological malignancies and solid tumors. In April 2025, CERo initiated clinical trials for its lead product candidate, CER-1236,for hematological malignancies. Forward-Looking Statements This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'strive,' 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERo's management. Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERo's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April 15, 2025, and the documents incorporated by reference therein. The risks described in CERo's filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time, and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Contact:Chris EhrlichChief Executive Officerchris@ Investors:CORE IRinvestors@ in to access your portfolio
Yahoo
44 minutes ago
- Yahoo
AAM to Present at the Deutsche Bank 2025 Global Auto Industry Conference on June 11
DETROIT, June 6, 2025 /PRNewswire/ -- American Axle & Manufacturing Holdings, Inc. (AAM), (NYSE: AXL) will participate in the Deutsche Bank 2025 Global Auto Industry Conference on June 11. AAM is scheduled to webcast the fireside chat presentation at 1:25 p.m. ET. The live audio webcast will be accessible through the Investor Relations page on AAM's website ( A replay of the webcast will be available following the event. About AAMAs a leading global Tier 1 Automotive and Mobility Supplier, AAM designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles. Headquartered in Detroit, MI, with over 75 facilities in 16 countries, AAM is bringing the future faster for a safer and more sustainable tomorrow. To learn more, visit Our presentation may contain "forward-looking" statements that are subject to risks and uncertainties described in our most recent filings on Form 10-K and Form 10-Q with the Securities and Exchange Commission, and actual results may differ materially. Our presentation may also include certain non-GAAP financial measures. Information regarding these non-GAAP measures, as well as a reconciliation of these non-GAAP measures to GAAP financial information, is available on AAM's website. For more information: Investor Contact: David H. LimHead of Investor Relations(313) Media Contact: Christopher M. Son Vice President, Marketing & Communications (313) 758-4814 Or visit the AAM website at View original content to download multimedia: SOURCE American Axle & Manufacturing Holdings, Inc. Sign in to access your portfolio
